期刊文献+

佛山地区人乳头瘤病毒感染亚型分析 被引量:2

An investigation of epidemiology of HPV subtypes infection in Foshan city
下载PDF
导出
摘要 目的 分析佛山地区人乳头瘤病毒感染亚型的分布情况.方法 对2008年11月~2009年10月在佛山市妇幼保健院宫颈疾病诊疗中心就诊的1 714例女性患者,采集宫颈脱落细胞,行反向点杂交人乳头瘤病毒基因分型检测和美国新柏氏细胞学检测.分析佛山地区人乳头瘤病毒亚型分布情况.结果 检测出570人(33.26%)感染了包括21种亚型的784个人乳头瘤病毒,其中HPV16亚型最高(21.95%),其次为HPV52(16.70%).16~25岁患者人乳头瘤病毒感染亚型以HPV6(19.78%)和HPV11(10.07%)为主;26~35岁患者人乳头瘤病毒感染亚型以HPV16(19.30%)和HPV6(17.09%)为主;36~45岁患者人乳头瘤病毒感染亚型以HPV16(18.92%)和HPV52(16.89%)为主;46岁以上患者人乳头瘤病毒感染亚型以HPV52(19.6%)为主.结论 反向点杂交基因芯片法可有效用于人乳头瘤病毒的检测和基因分型,佛山地区人乳头瘤病毒感染亚型分布具有明显的地域性. Objective To investigate epidemiology of human papillomavirus (HPV) subtypes infection in Foshan city. Methods The cervical exfoliatied cells of 1 714 women who received gynecological examination in Cervical Disease Diagnosis and Treatment Center of Foshan Municipal Maternal and Child Health Hospital in a period from November, 2008 to October, 2009 were taken and analyzed for genotyping of HPV with array of reverse dot blot hybridization (RDB) and thin prep cytological test (TCT). Results 570 women were infected by 784 HPVs, which belong to 21 subtypes including HPV subtypes 16, 18, 31, 33, 35, 39, 45, 51,52, 53, 56, 58, 59, 66, 68, 73, 83, 6, 11,42 and 43 with the positive HPV infection rate of 33.26% (570/1714). Of which, the most common HPV genotypes were HPV-16(21.95% )and HPV52( 16.70% ). The women aged 16 -25 years were mainly infected by genotypes of HPV6 (19.78%) and HPV11 ( 10.07% ), those women aged 26 - 35 years old were mainly infected by genotypes of HPV16 ( 19.30% ) and HPV6 ( 17. 09% ), those women aged 36 - 45 years were mainly infected by genotypcs of HPV16 (18.92% )and HPV52 ( 16.89% )and those women aged 〉45 years were mainly infected by genotype of HPV52( 19.6% ). Conclusion RDB technique is an effective method to detect and genotype HPV. The distribution of HPV genotypes infection in Foshan area is significantly regional.
出处 《中国妇幼健康研究》 2010年第3期332-335,共4页 Chinese Journal of Woman and Child Health Research
关键词 人乳头瘤病毒 基因分型 宫颈癌 基因芯片 human papillomavirus (HPV) genotyping cervical cancer gene chip
  • 相关文献

参考文献7

  • 1Didelot R M N,Nagot N,Costes M V,et al.Human papillomavirus genotype distribution and cervical squamous intraepithelial lesions among high-risk women with and without HIV-1 infection in Burkina Faso[J].British Journal of Cancer,2006,95(8):355-362.
  • 2CHEN Wen,ZHANG Xun,Molijn A,et al.Human papillomavirus type-distribution in cervical cancer in China:The importance of HPV 16 and 18[J].Cancer Causes Control,2009,20(8):1705-1713.
  • 3Faradian S,Asadi E,Doroudchi M,et al.High risk HPV types in southern iranian patients with cervical cancer[J].Pathology Oncology Research,2003,9(2):121-125.
  • 4徐海燕,辛晓燕.人乳头瘤病毒感染与宫颈癌的研究进展[J].中国妇幼健康研究,2007,18(5):436-440. 被引量:10
  • 5Madkan V K,Cook N R H,Steadman M C,et al.The oncogenic potential of human papillomaviruses:A review on the role of host genetics and environmental cofactors[J].British Journal of Dermatology,2007,157(3):228-241.
  • 6Moore R A,Ogilvie G,Fornika D.Prevalence and type distribution of human papillomavirus in 5 000 British Columbia women-implications for vaccination[J].Cancer Causes Control,2009,20(5):1387-1396.
  • 7张新,王纯雁,石菊芳,高岩,李联昆.沈阳市妇女人乳头瘤病毒感染型别分布的研究[J].中华流行病学杂志,2007,28(10):954-957. 被引量:17

二级参考文献37

  • 1[1]Chen Z,Terai M,Fu L,et al.Diversifying selection in human papillomavirus type 16 lineages based on complete genome analyses[J].J Virol,2005,79(11):7014-7023.
  • 2[2]Jungw W,ChunL S D.Strategies against human papillomavlms infection and cervical cancer[J].Microbiol,2004,42(4):255-266.
  • 3[3]Munoz N,Bosch F X,De Sanjose S,et al.Epidemiologic classification of human papillomavirus types associated with cervical cancer[J].N Engl J Med,2003,348:518-527.
  • 4[4]Franceschi S.The LARC commitment to cancel-prevention:The exanlpie of papillomavirus and cervical cancer[J].Recent Results Cancer Res,2005,166:277-297.
  • 5[5]Ahekruse S F,Laeey J V J,Brinton I A,et al.Comparison of human papillomavirus genotype sexual,and reproductive risk factors of cervical adenocarcinoma and squamous cell carcinoma[J].Am J Obstet Gynecol,2003,188(3):657-663.
  • 6[6]Banuelos A,Reyes E,Ocadiz R,et al.Neocarzinostatin induces an effective p53-dependent response in human papillomavirus positive cervical cancer cells[J].J Pharmacol Exp Ther,2003,306(2):671-680.
  • 7[7]Neville F H,Jonathan S B,Barbara L A,et al.Paractical gynecologic oncology[M].4/E,United States:Arrangement with Lippincort Williams and Wilkins,2005.215-224.
  • 8[8]Wang L P.Progress in research and countermeasures on relationship between papillomavirus infection and cervical carcinma[J].J Diag Pathol,2007,14(2):86-89.
  • 9[9]Sandri M T,Lentati P,Benini E,et al.Comparison of the digene HC2 assay and the roche amplicor human papillomavirus (HPV) test for detection of high2risk HPV genotypes in cervical samples[J].J Clin Microbiol,2006,44(6):2141-2146.
  • 10[10]De Villiers E M.Relationship between steroid hormone contraceptives and HPV,cervical intraepithelial neoplasia and cervical carcinoma[J].Int J Cancer,2003,103(6):705-708.

共引文献25

同被引文献42

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部